Corticosteroid-induced osteoporosis

Seminars in Arthritis and Rheumatism

Volumn 22, Issue 6, 1993, Pages 375-384

  Adachi, Jonathan D ^a   Bensen, William G ^a   Hodsman, Anthony B ^a  

^a NONE

Author keywords

Corticosteroids; osteoporosis

Indexed keywords

CALCIUM; CORTICOSTEROID; ETIDRONIC ACID; FLUORIDE; THIAZIDE DIURETIC AGENT; VITAMIN D;

BONE ATROPHY; BONE MINERALIZATION; HUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VERTEBRA FRACTURE;

ADRENAL CORTEX HORMONES; FEMALE; HUMAN; MALE; OSTEOPOROSIS;

EID: 0027159504     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(05)80029-0     Document Type: Article

References (67)

1. The basophil adenomas of the pituitary body and their clinical manifestations
2. Isolated skeletal involvement in Cushing's syndrome: Response to therapy
3. Histomorphometric profile, pathophysiology and reversibility of corticosteroid induced osteoporosis
4. Steroid induced fractures and bone loss in patients with asthma
5. Reduction of serum 1,25-dihydrovitamin D in children receiving glucocorticoids
6. Production degradation and circulating levels of 1,25-dihydroxyvitamin D in health and chronic glucocorticoid excess
7. Parathyroid hormone and 25-hydroxyvitamin D levels in glucocorticoid-treated patients
8. Short-term effect of prednisone on serum 1,25-dihydroxyvitamin D in normal individuals and in hyper and hypoparathyroidism
9. Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: Relationship to calcium and phosphorous homeostasis
10. Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man
11. Effects of prednisone on vitamin D metabolism in man
12. Intestinal calcium absorption in exogenous hypercortisolism: role of 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy
13. Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy
14. Alternations in mineral and vitamin D metabolism produced by subacute prednisone administration in man
15. The effect of prednisone on the metabolism and action of 25-hydroxy and 1,25-dihydroxyvitamin D
16. Effect of glucocorticoids on function of the parathyroid glands in man
17. Calcium and phosphorus homeostasis in man: Effect of corticosteroids
18. Osteopenia in patients with rheumatic diseases: Principles of diagnosis and therapy
19. Altered mineral metabolism in glucocorticoid induced osteopenia: Effect of 25-hydroxyvitamin D administration
20. The effect of cortisone on lamellar osteoblastic activity
21. Bone formation in hypercortisolism
22. Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis
23. Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro
24. Corticosteroid and bone
25. Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat
26. Effects of cortisone administration on the metabolism and localization of 25-hydroxycholecalciferol in the rat
27. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy
28. Drug induced disorders of vitamin D and mineral metabolism
29. Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects
30. Reversible gonadotrophin deficiency in male Cushing's disease
31. Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells
32. Cortisol-induced suppression of plasma testosterone in normal adult males
33. Effect of glucocorticoids on plasma testosterone in men
34. Reduction of serum testosterone levels during chronic glucocorticoid therapy
35. Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women
36. Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving B-estradiol
37. Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass
38. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography
39. Glucocorticoids and bone
40. Corticosteroid induced osteoporosis: Followup over 3 years
41. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases
42. Determinant of axial bone loss in rheumatoid arthritis
43. The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects
44. Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women
45. Radiologic aspects of glucorticoid-induced bone disease
46. Glucorticoid-induced osteoporosis: Pathogenesis and management
47. Differential effects of endocrine dysfunction on the axial and appendicular skeleton
48. Roentgenologic changes of the skeletal system in Cushing's syndrome
49. Quantitative microradiographic study of bone remodelling in Cushing's syndrome
50. Effect on bone growth of daily versus alternate day corticosteroid administration: An experimental study
51. Bone loss in adults receiving alternate day glucocorticoid therapy
52. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans
53. Responses of patients with glucocorticoid osteopenia to oral 1,25-dihydroxyvitamin D
54. Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients
55. Vitamin D toxicity complicating the treatment of senile, postmenopausal, and glucocorticoid-induced osteoporosis. Four case reports and a critical commentary on the use of vitamin D in these disorders
56. Estrogen and progesterone repaacement therapy reduces glucocorticoid-induced bone loss
57. Corticosteroids and osteoporosis
58. Treatment with fluoride: Bone histomorphometric findings
59. Mineral loss in cortical and trabecular bone during high dose prednisone treatment
60. Salmon calcitonin in the therapy of corticoid-induced osteoporosis
61. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study
62. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients
63. Nasal salmon calcitonin in the prevention of corticosteroid-induced osteoporosis
64. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)
65. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
66. Effect of cyclical etidronate regimen on prophylaxis of bone loss of glucocorticoid (prednisone) therapy in postmenopausal women